If you are interested in showcasing your company’s services to senior clinical development executives from Chinese and US BioPharmas, please contact: firstname.lastname@example.org.
PPC was established in 1997 and is a subsidiary of Novotech Health Holdings ("Novotech"). Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech Health Holdings is positioned to serve biopharmaceutical clients conducting clinical trials in Asia and globally. As of August 31, 2021, NHH had a total of 2,075 FTEs working across our offices in 14 geographies in Asia-Pacific and the United States.
Redbud Medicine is a strategic CRO partner rooted in China and U.S., which are two important drug R&D markets in the world. By implementing artificial intelligent technology, Redbud optimizes every single process within clinical trial, and ultimately lower the operation cost and accelerate the clinical study process.
Redbud brings a nimble and stage-appropriate approach to clinical development. This ensures that activities are streamlined and resources conserved in early stages, while building a solid foundation for the greater complexity of later development stages.
Redbud team are practical and science-driven. The experienced team helps you avoid common development pitfalls. Ultimately Redbud relies on good science to make good decisions.
In terms of globalization, Redbud Medicine is at the forefront of the industry.
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. With a broad portfolio of services and a promise of quality, from clinical development to commercialization, we are committed to moving our customers and patients through their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 80 subsidiaries and 170 offices and sites, with over 8,000 employees across 46 countries in Asia Pacific, Europe, North & South America and Africa. We are devoted to building an integrated platform that enables boundless possibility for the healthcare industry, embracing challenges to fulfill our commitment to serve unmet patients’ needs, and eventually saving lives.
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Lilly has approximately 34,000 employees worldwide, research and development facilities located in 7 countries, manufacturing plants located in 7 countries, clinical research conducted in more than 55 countries. Lilly’s products are marketed in 120 countries and regions.
Lilly’s history with China can be traced back to the early 20th Century. Lilly set up its first over-seas office in Shanghai in 1918 which was our first step into its global presence. Over the past 20 years, we have been adhering to the principle of “In China For China” and forging ahead in de-veloping our business in China. Lilly China is now the second largest branch of Eli Lilly world-wide with presence in almost 400 cities in China.
As the expert in global supply chain for clinical trials, Taikun Pharma is dedicated to providing international standard supply chain services for our clients.
Whether it is assisting Chinese pharmaceutical R&D expand overseas, or to facilitate international pharmaceutical projects to land in China, Taikun Pharma always commits to the mission of offering professional and advanced services to match best quality whole-supply chain solutions, propelling a smooth journey towards the destination of your clinical trials.
With professional GDP/GMP compliant depots established in Shanghai (China), New Jersey (USA) and Melbourne (Australia), Taikun Pharma provides a full range of professional clinical trial supply chain services covering supply chain management, GCP/GMP compliant packaging solutions, label and carton design and manufacturing, temperature-controlled storage, global clinical trial distribution, investigational product return and destruction, etc.
Guided by the mission of accelerating the accessibility of innovative drugs, Taimei Technology is forming the infrastructure for the future development of pharmaceutical industry. Our goals are to accelerate the process of new drug R&D, improve drug accessibility, ensure patients’ safety use of drugs and reduce the patient's medical burden.
As the digital operation platform for life science industry, Taimei Technology aims at empowering our clients across pharmaceutical R&D, pharmacovigilance and marketing with the comprehensive professional software product suite and technology-based innovation service system.
Led by the core concept of “cooperation”, our TrialOS platform integrate stakeholders from pharmaceutical enterprises, GCP sites, providers, regulators, patients to other stakeholders. We are poised to advance the value upgrade and realize a win-win situation for all parties by leveraging resource integration, data interaction, process cooperation and standard unification.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With more than 28,000 professionals worldwide, PPD has conducted clinical trials in more than 100 countries to help customers deliver life-changing therapies to improve health. We apply innovative technologies, therapeutic expertise and a firm commitment to quality to bend the cost and time curve of drug development and optimize value. For more information, visit www.ppd.com.
ESTABLISHED IN 2018, AMADOR IS COMMITTED TO PROVIDE HIGH-QUALITY, TIMELY AND COST-EFFECTIVE SERVICES TO SUPPORT THE DEVELOPMENT OF NOVEL THERAPEUTICS
Our leadership team members have extensive drug development experience at leading biopharmaceutical companies or global CROs. Our AWS-based computer system and software are fully validated. With an implemented QMS, Amador has passed multiple qualification and audits without major findings.
As of July 2021, Amador has supported 6 successful BLA/NDA submissions for US, EU, China and MNC clients, providing services in clinical pharmacology, pharmacometrics, immunogenicity, SAS programming, project management and medical writing.
Aurora (Yaocheng Healthcare Technology) focuses on the life sciences clinical research management to provide a global leading SaaS platform for transforming clinical operations and clinical data management with the most comprehensive suite of clinical solutions. Enable technology-driven process improvements throughout the trial for data quality, operation efficiency, and cost controlling. Aurora’s experienced talents come from several global leading companies like Google, Verily, Splunk, Medidata, Veeva, & etc.
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With ten GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries. Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
With the mission of "Innovative Technology, Better Treatment", EClinCloud is a life sciences technology company based in China dedicated to serving the international community. Through EClinCloud's seamlessly integrated platform (including Scale Management, Linguist Validation, Study Design, eCOA, EDC, CTMS, eTMF) and varied therapeutic fields expertise (Oncology, Neurology, Cardiology, Respiratory, Dermatology, etc.), EClinCloud is building the world's leading "patient-centered" SaaS cloud platform. Its aim is to partner with pharmaceutical companies and research institutions to improve research and development efficiency for new drugs and medical devices in order to deliver therapies to patients faster.
For more information, please visit: www.eclincloud.com.
Beijing Improve-Quality Tech Co., Ltd. founded in 2015, focuses on clinical data management and statistical services, specializing in oncology, class I new drug and first generic drug development, and is the first CDISC corporate member in China. The core members graduated from top medical universities with average master's degree and have undertaken 200+ new class 1.1 drug registration projects. We have established good scientific cooperation with Peking University School of Medicine, Peking Union Medical College, Xiyuan Hospital, China-Japan Friendship Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Friendship Hospital, etc.
Invest Northern Ireland
Invest Northern Ireland is the region’s economic development agency. It helps new and existing businesses to compete internationally and attract new investment to Northern Ireland. Northern Ireland is a prime location for Life and Health Sciences businesses, thanks to a unique combination of talented people, world-class research and strong links between industry, academia and clinicians, in the commercialisation of innovative research. Our sector expertise: Precision Medicine, Pharma & Biotech, Clinical Trials, Diagnostics and MedTech. To learn more visit our website: www.investni.com or get in contact with a member of our Life and Health Sciences team: Beijing@investni.com
Shanghai Jsure Health Technology Co., Ltd. was established in 2008. Jsure Health is a provider of digital solutions for patients while adhering to a "patient-centered" philosophy. Jsure’s business scope covers more than 40 different types of diseases. Additionally, Jsure Health has developed close relationships with 200+ sites and 5,000+ physicians. So far, Jsure Health has brought hope to 80,000+ patients, while over 50 new drugs have had accelerated approvals to be listed with Jsure Health’s efforts.
Linking the patients to hope and building new models for digital clinical research. Jsure is continuously promoting the development of healthcare.
Oceanus-Plus is a high tech company focusing on providing integrated platform solutions for clinical research. It covers all-round services in phase I-IV clinical research, clinical trial (IIT) initiated by investigator, Real World Study(RWE / RWS). The platform solution aims at supporting all the coordination effort among different users/stakeholders within clinical research projects.
Till 2021 ,Oceanus have been supporting over 900 clinical research projects (Registration & Scientific Research ) in China , and building strategic partnership with over 40 well-known hospitals 。
Oceanus was established in 2013, headquarter located in Shanghai, and R&D center was built in Suzhou Biopay Park.
Premier Research, a clinical research company, is dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments.
As a global company, Premier Research specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.
Whether it's developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.
Sanofi is a leading global biopharmaceutical company focused on human health. In 1982, Sanofi opened an office in China as one of the first multinational corporations to support China’s opening up and reform. Sanofi China has a diversified business that ranges from pharmaceuticals and human vaccines to consumer healthcare. We have 12 offices, 3 production sites, 4 R&D sites and 1 digital innovation hub in China. Sanofi is committed to introducing innovative medicines and vaccines faster in China, and leading digital innovations to serve the broadest base of the Chinese people.
Since 2015, headquarter in Shanghai, Suzhou, Guangzhou and Hangzhou have R&D and operation centers; Core team from Roche, IQVIA, IBM, Oracle etc. with 10+ years clinical experience on average; 6+ years focus on high quality digital solutions to medical research; to be one of the most respected health companies.
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 27,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
Viedoc is European leading developer of e-Clinical systems, a game-changing software for capturing and evaluating data in clinical research. Since the launch in 2003, Viedoc has been used in thousands of clinical studies in over 75 countries around the world, making us one of the fastest-growing companies in its field, globally. The company head office is located in Uppsala, Sweden with local offices in Shanghai, China, US, France and Japan. In addition to our local offices, we are proud to maintain a strong international presence with representatives all over the world. Contact: Percy Wu; email@example.com; +86-135-0185-7153